2026 年至 2032 年人工腎臟市場（按設備類型、最終用戶、透析和地區分類）

2026-2032年人工腎臟市場評估

需要透析的患者數量不斷增加，腎臟替代療法的技術進步，例如穿戴式和可植入的人工腎臟，也正在推動市場創新。 2024年人工腎臟的需求將超過664.9億美元，到2032年將達到6,055億美元。

此外，人們對腎臟移植益處的認知不斷提高以及新興國家醫療保健基礎設施的不斷擴大也促進了市場擴張。這些因素推動了各行業人工腎臟使用量的增加，預計從 2026 年到 2032 年，人工腎臟的複合年成長率將達到 35.08%。

人工腎臟市場定義/概述

人工腎臟，也稱為透析機，是一種執行天然醫療設備基本功能的醫療設備，例如過濾血液中的廢物和多餘的液體，維持體內電解質平衡，以及防止毒素積聚。其主要用於治療慢性腎臟病和急性腎衰竭，為無法接受腎臟移植的患者提供維持生命的腎臟替代療法。未來，生物技術和奈米技術的進步有望推動更高效、更便攜的人工腎臟的開發，從而可能帶來生物工程器官和提供持續透析治療的穿戴式設備等創新。

對具有成本效益的治療的需求不斷成長，將推動人工腎臟市場的發展嗎？

慢性腎臟病(CKD) 盛行率的上升和對具有成本效益的治療方案的需求的不斷成長正在極大地推動人工腎臟市場的發展。根據美國疾病管制與預防中心 (CDC) 的數據，美國約有 3,700 萬成年人患有 CKD，另有數百萬人面臨患病風險。隨著醫療保健領域轉向基於價值的護理，醫療保健提供者擴大尋求可負擔的解決方案，使他們能夠提供有效的治療，而無需承擔腎臟移植和長期住院的高昂費用。

此外，腎臟疾病的經濟負擔也增加了對更容易獲得的治療方法的需求。根據美國糖尿病、消化和腎臟疾病研究所 (NIDDK) 的報告，末期腎功能衰竭(ESRD) 患者每年的透析費用每人可超過 90,000 美元，這對患者和醫療保健系統來說都是沉重的經濟負擔。因此，旨在降低治療成本和提高效率的人工腎臟技術創新對於滿足日益成長的經濟實惠的醫療保健解決方案的需求同時改善患者的治療效果至關重要。

資料安全和隱私問題會阻礙人工腎臟市場的成長嗎？

資料安全和隱私問題對人工腎臟市場的成長構成了重大挑戰，尤其是在技術進步導致數位健康解決方案與醫療設備結合的情況下。人工腎臟，尤其是連接到遠端醫療平台和監控系統的人工腎臟，會收集和傳輸敏感的患者訊息，包括健康數據和治療歷史。醫療保健領域網路攻擊和資料外洩事件日益頻繁，引發了人們對這些資訊可能被濫用的擔憂，使得患者和服務提供者不願採用這些創新解決方案。

此外，美國的《健康保險互通性與課責法案》（HIPAA）等嚴格的資料保護法規要求製造商在安全技術和合規措施方面進行大量投資。這些複雜性和額外成本可能會減緩人工腎臟的開發和廣泛應用，尤其是對於中小型企業而言。由於患者信任在醫療保健中至關重要，透過強力的資料保護措施和透明的做法解決這些安全問題對於建立對人工腎臟技術的信任和確保持續的市場成長至關重要。

目錄

第1章全球人工腎臟市場介紹

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章全球人工腎臟市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章 全球人工腎臟市場（依設備類型）

• 概述
• 穿戴式人工腎
• 植入式人工腎

第6章 全球人工腎臟市場（依最終用戶）

• 概述
• 醫院
• 專科診所

第7章 全球人工腎臟市場（按透析設備）

• 概述
• 血液透析機
• 腹膜透析

第8章 全球人工腎臟市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 拉丁美洲
  • 中東和非洲

第9章全球人工腎臟市場的競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第10章 公司簡介

• B. Braun Melsungen AG
• Asahi Kasei Medical Co. Ltd.
• DaVita Inc.
• NIPRO Medical Corporation
• Nikkiso Co., Ltd.
• Fresenius Medical Care AG & Co. KGaA
• Baxter
• Merit Medical Systems
• Medtronic
• Xcorporeal, Inc.

第11章 附錄

• 相關調查

Artificial Kidney Market Valuation - 2026-2032

The increasing number of patients requiring dialysis. Technological advancements in kidney replacement therapies, such as wearable and implantable artificial kidneys, are also driving innovation in the market. The need for artificial kidney is surpassing USD 66.49 Billion in 2024 and reaching USD 605.5 Billion by 2032.

Additionally, the growing awareness of the benefits of kidney transplantation and the expanding healthcare infrastructure in emerging economies contribute to market expansion. These factors contribute to the increasing use of artificial kidney in a variety of industries is expected to grow at a CAGR of 35.08% about from 2026 to 2032.

Artificial Kidney Market: Definition/ Overview

An artificial kidney, also known as a dialysis machine, is a medical device that performs the essential functions of a natural kidney by filtering waste products and excess fluids from the blood, thereby maintaining the body's electrolyte balance and preventing the accumulation of toxins. Its primary application is in the treatment of individuals with chronic kidney disease or acute kidney injury, providing life-sustaining renal replacement therapy for patients who cannot undergo kidney transplantation. Looking to the future, advancements in biotechnology and nanotechnology hold promise for the development of more efficient and portable artificial kidneys, potentially leading to innovations such as bioengineered organs and wearable devices that offer continuous dialysis treatment, significantly enhancing patients' quality of life and reducing the need for traditional dialysis sessions.

Will Rising Demand for Cost Effective Treatment is Propelling the Artificial Kidney Market?

The increasing prevalence of chronic kidney disease (CKD) and the growing demand for cost-effective treatment options are significantly propelling the artificial kidney market. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States have CKD, and millions more are at risk. As the healthcare landscape shifts towards value-based care, healthcare providers are increasingly seeking affordable solutions that can deliver effective treatment without the high costs associated with kidney transplants or prolonged hospital stays.

Furthermore, the economic burden of kidney diseases necessitates the need for more accessible treatment options. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that the annual cost of dialysis for patients with end-stage renal disease (ESRD) can exceed $90,000 per patient, underscoring the financial strain on both patients and healthcare systems. As a result, innovations in artificial kidney technologies, aimed at reducing treatment costs and enhancing efficiency, are essential to meet the rising demand for affordable healthcare solutions while improving patient outcomes.

Will Data Security and Privacy Concerns Hamper the Growth of the Artificial Kidney Market?

Data security and privacy concerns pose significant challenges to the growth of the artificial kidney market, particularly as advancements in technology integrate digital health solutions with medical devices. Artificial kidneys, especially those connected to telemedicine platforms or monitoring systems, collect and transmit sensitive patient information, including health data and treatment history. The increasing frequency of cyberattacks and data breaches in healthcare raises alarms about the potential misuse of this information, which can deter patients and healthcare providers from adopting these innovative solutions.

Moreover, stringent regulations regarding data protection, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, require manufacturers to invest heavily in secure technology and compliance measures. This added layer of complexity and cost can slow down the development and deployment of artificial kidneys, particularly for smaller companies. As patient trust is paramount in healthcare, addressing these security concerns through robust data protection measures and transparent practices will be crucial for fostering confidence in artificial kidney technologies and ensuring sustained market growth.

Category-Wise Acumens

Will Increasing Adoption of Wearable Devices Boost the Artificial Kidney Market?

The rising adoption of wearable devices is expected to significantly boost the artificial kidney market by enhancing patient engagement and facilitating remote monitoring of kidney health. Wearable technologies, such as smartwatches and health trackers, are increasingly being integrated with advanced monitoring systems that can provide real-time data on vital signs, fluid balance, and kidney function. This integration empowers patients to take an active role in managing their health, leading to timely interventions and improved outcomes.

Moreover, the growing trend of telemedicine and remote patient monitoring is driving demand for wearable artificial kidneys, as healthcare providers seek efficient ways to manage chronic conditions without the need for frequent hospital visits.

The implantable artificial kidney segment is the fastest-growing segment, driven by advancements in bioengineering and materials science that aim to create devices capable of mimicking natural kidney functions more effectively.

Will Widespread Availability of Advanced Technologies in Hospitals Fuel the Artificial Kidney Market?

The widespread availability of advanced technologies in hospitals is significantly fueling the artificial kidney market by enhancing the efficiency and effectiveness of renal care. Innovations such as portable dialysis machines, automated systems, and remote monitoring capabilities are making it easier for healthcare providers to deliver high-quality care.

These advancements enable hospitals to offer more comprehensive treatment options, reducing the need for patients to seek alternatives, which in turn drives demand for artificial kidneys. Moreover, the integration of artificial intelligence and data analytics into renal care is improving patient outcomes through personalized treatment plans and real-time monitoring of patient health.

Specialty Clinics is the fastest-growing segment, driven by the increasing trend towards outpatient care and the desire for more personalized treatment options.

Country/Region-wise

Will the Technological Advancement in North America Drive the Expansion of The Artificial Kidney Market?

Technological advancements in North America are poised to significantly drive the expansion of the artificial kidney market. Innovations such as miniaturization of dialysis devices, the integration of artificial intelligence for personalized treatment, and the development of wearable dialysis systems are enhancing the accessibility and efficiency of renal replacement therapies. According to the U.S. Renal Data System, as of 2021, over 786,000 individuals were undergoing dialysis in the United States, and advancements in technology could help meet the growing demand for more effective and convenient treatment options.

Moreover, the increasing investment in research and development, alongside supportive government initiatives, is further propelling market growth. The National Institutes of Health (NIH) reported funding of approximately $690 million in 2022 for kidney disease research, which aims to foster innovations in artificial kidneys and improve patient outcomes. Such financial backing, combined with the rising prevalence of chronic kidney disease-projected to affect about 37 million adults in the U.S. by 2030-underscores the vital role of technological progress in shaping the future of the artificial kidney market.

Will Increasing Number of Well-Equipped Hospitals in Asia Pacific Propel the Artificial Kidney Market?

The increasing number of well-equipped hospitals in the Asia Pacific region is expected to significantly propel the artificial kidney market. As healthcare infrastructure improves, more hospitals are investing in advanced medical technologies, including dialysis machines and artificial kidney devices. According to the World Bank, the number of hospitals in the Asia Pacific region has grown by approximately 20% from 2010 to 2020, reflecting the region's commitment to enhancing healthcare services. This growth not only increases access to treatment for patients with chronic kidney disease but also encourages the adoption of advanced dialysis technologies, thereby expanding the artificial kidney market.

Furthermore, government initiatives aimed at improving healthcare access and the growing prevalence of kidney-related disorders are driving demand for artificial kidneys. The Asia Pacific region accounted for nearly 50% of global end-stage renal disease cases in 2021, as reported by the Global Burden of Disease Study. With an aging population and lifestyle-related health issues on the rise, the need for artificial kidneys is expected to surge. Coupled with the expanding hospital infrastructure, this demand presents a lucrative opportunity for manufacturers and healthcare providers, reinforcing the positive outlook for the artificial kidney market in the region.

Competitive Landscape

The competitive landscape of the artificial kidney market is characterized by a mix of established players and emerging startups, each focusing on innovative features such as real-time tracking, integration with IoT devices, and user-friendly interfaces. Companies are increasingly investing in research and development to enhance product offerings and improve customer service, creating a dynamic and rapidly evolving market environment.

Some of the prominent players operating in the artificial kidney market include:

Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., DaVita Inc., NIPRO Medical Corporation, Nikkiso Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Baxter, Merit Medical Systems, Medtronic, Xcorporeal, Inc.

Latest Developments

In August 2024 Reistone Biopharma reported significant progress in its clinical trials for an innovative artificial kidney that utilizes bioengineered materials to mimic natural kidney function. Preliminary results have shown promising outcomes in terms of biocompatibility and efficacy, paving the way for future regulatory approvals. The company aims to revolutionize renal replacement therapy by providing a more efficient and long-lasting solution for patients with chronic kidney disease.

In July 2024 Dialyze Direct announced the expansion of its home dialysis services, integrating artificial kidney technology into their offerings. This initiative aims to provide patients with greater flexibility and comfort by enabling them to manage their treatment at home. The company is focused on enhancing patient education and support to ensure successful adoption of these advanced technologies in home settings.

In June 2024 Xeltis unveiled groundbreaking results from its research on bioengineered kidneys, which utilize a unique combination of synthetic and biological materials to promote kidney regeneration. The company's innovative approach aims to create a functional artificial kidney that not only replaces lost function but also encourages tissue regeneration.

Artificial Kidney Market, By Category

• Device Type
• Wearable Artificial Kidney
• Implantable Artificial Kidney
• End-user
• Hospitals
• Specialty Clinics
• Dialysis
• Hemodialysis
• Peritoneal Dialysis
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ARTIFICIAL KIDNEY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ARTIFICIAL KIDNEY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ARTIFICIAL KIDNEY MARKET, BY DEVICE TYPE

• 5.1 Overview
• 5.2 Wearable Artificial Kidney
• 5.3 Implantable Artificial Kidney

6 GLOBAL ARTIFICIAL KIDNEY MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Specialty Clinics

7 GLOBAL ARTIFICIAL KIDNEY MARKET, BY DIALYSIS

• 7.1 Overview
• 7.2 Hemodialysis
• 7.3 Peritoneal Dialysis

8 GLOBAL ARTIFICIAL KIDNEY MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ARTIFICIAL KIDNEY MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 B. Braun Melsungen AG
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Asahi Kasei Medical Co. Ltd.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 DaVita Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 NIPRO Medical Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Nikkiso Co., Ltd.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Fresenius Medical Care AG & Co. KGaA
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Baxter
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Merit Medical Systems
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Medtronic
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Xcorporeal, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research